SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr | ₹9.37 Cr |
What is the latest Total Non-Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹1.01 Cr |
| Mar2021 | ₹9.37 Cr |
How is Total Non-Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 20.42 | |
| Mar2024 | ₹11 Cr | 33.16 | |
| Mar2023 | ₹8.14 Cr | 709.34 | |
| Mar2022 | ₹1.01 Cr | -89.26 | |
| Mar2021 | ₹9.37 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹116.6 Cr | -5.4% | -2.8% | -8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.4% |
-2.8% |
-8.3% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses